HEXO Corporation (HEXO) Receives a Buy from GMP FirstEnergy


HEXO Corporation (HEXO), was revisited by a Wall Street analyst on December 14. Analyst Robert Fagan from GMP FirstEnergy reiterated a Buy rating, with a C$8 price target on December 14.

According to TipRanks.com, Fagan is ranked #2573 out of 5105 analysts.

Currently, the analyst consensus on HEXO Corporation is a Strong Buy with an average price target of C$9.33.

Based on HEXO Corporation’s latest earnings release for the quarter ending July 31, the company reported a quarterly GAAP net loss of C$10.51 million. In comparison, last year the company had a GAAP net loss of C$1.92 million.

HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on August 13, 2013 and is headquartered in Gatineau, Canada.

The company’s shares closed on Friday at C$4.95.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts